26288 Federal Register / Vol. 83, No. 109 / Wednesday, June 6, 2018 / Notices 

safety and health education, 

ergonomics, epidemiology, biostatistics, 

and psychology. Federal employees will 

not be considered for membership. 

Members may be invited to serve for up 

to four-year terms. Selection of members 

is based on candidates’ qualifications to 

contribute to the accomplishment of the 

board’s objectives http://www.cdc.gov/ 

niosh/BSC/default.html. 

DATES: Nominations for membership on 

the BSC must be received no later than 

August 1, 2018. Packages received after 

this time will not be considered for the 

current membership cycle. 

ADDRESSES: All nominations should be 

mailed to NIOSH Docket 278, c/o 

Pauline Benjamin, Committee 

Management Specialist, National 

Institute for Occupational Safety and 

Health, Centers for Disease Control and 

Prevention, 1600 Clifton Rd. NE, MS: 

E–20, Atlanta, Georgia 30329, or 

emailed (recommended) to 

nioshdocket@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Alberto Garcia, M.S., DFO, CDC/NIOSH, 

1090 Tusculum Ave. MS R–5, 

Cincinnati, OH 45226, telephone (513) 

841–4596; agarcia1@cdc.gov. 

SUPPLEMENTARY INFORMATION: The U.S. 

Department of Health and Human 

Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented, and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens, 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees (SGEs), requiring the filing 

of financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for NIOSH BSC membership each year, 

and provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in January 2019, or 

as soon as the HHS selection process is 

completed. Note that the need for 

expertise varies from year to year and a 

candidate who is not selected in one 

year may be reconsidered in a 

subsequent year. SGE Nominees must be 

U.S. citizens, and cannot be full-time 

employees of the U.S. Government. 

Candidates should submit the following 

items: 

D Current curriculum vitae, including 

complete contact information (telephone 

numbers, mailing address, email address). 

D At least one letter of recommendation 

from person(s) not employed by the U.S. 

Department of Health and Human Services. 

(Candidates may submit letter(s) from current 

HHS employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, NIH, 

FDA, etc.). 

Nominations may be submitted by the 

candidate him- or herself, or by the 

person/organization recommending the 

candidate. The Director, Management 

Analysis and Services Office, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Elaine Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–12150 Filed 6–5–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Board on Radiation and 

Worker Health (ABRWH or the 

Advisory Board), Subcommittee on 

Dose Reconstruction Review (SDRR), 

National Institute for Occupational 

Safety and Health (NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Subcommittee for Dose 

Reconstruction Reviews (SDRR) of the 

Advisory Board on Radiation and 

Worker Health (ABRWH). This meeting 

is open to the public, but without a 

public comment period. The public is 

welcome to submit written comments in 

advance of the meeting, to the contact 

person below. Written comments 

received in advance of the meeting will 

be included in the official record of the 

meeting. The public is also welcome to 

listen to the meeting by joining the 

teleconference at the USA toll-free, dialin number at 1–866–659–0537; the pass 

code is 9933701. The conference line 

has 150 ports for callers. 

DATES: The meeting will be held on July 

24, 2018, 10:30 a.m. to 4:30 p.m. EDT. 

ADDRESSES: Audio Conference Call via 

FTS Conferencing. The USA toll-free 

dial-in number is 1–866–659–0537; the 

pass code is 9933701. 

FOR FURTHER INFORMATION CONTACT: 

Theodore Katz, MPA, Designated 

Federal Officer, NIOSH, CDC, 1600 

Clifton Road, Mailstop E–20, Atlanta, 

Georgia 30329, Telephone (513)533– 

6800, Toll Free 1(800)CDC–INFO, Email 

ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

rechartered on February 12, 2018, 

pursuant to Executive Order 13708, and 

will terminate on September 30, 2019. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 109 / Wednesday, June 6, 2018 / Notices 26289 

the health of members of this class. 

SDRR was established to aid the 

Advisory Board in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstruction. 

Matters To Be Considered: The agenda 

will include discussions on the 

following dose reconstruction program 

quality management and assurance 

activities: Dose reconstruction cases 

under review from Sets 19—24, 

including Iowa Ordinance Plant, 

Nevada Test Site, Los Alamos National 

Laboratory, Feeds Material Production 

Center (Fernald), Pantex Plant, Rocky 

Flats Plant, W.R. Grace, Hanford, 

Savannah River Site, Fernald, GE 

Evendale, Texas City Chemicals, Canoga 

Avenue Facility, De Soto Avenue 

Facility, Pacific Northwest National 

Laboratory, Amchitka Island Nuclear 

Explosion Site, Oak Ridge facilities, 

Paducah Gaseous Diffusion Plant, and 

potentially other Department of Energy 

and Atomic Weapons Employers 

facilities. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–12149 Filed 6–5–18; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–0920; Docket No. CDC–2018– 

0053] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Data Collection Through Web 

Based Surveys for Evaluating Act 

Against AIDS Social Marketing 

Campaign Phases Targeting Consumers 

which includes web surveys to test 

campaign messaging. 

DATES: CDC must receive written 

comments on or before August 6, 2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0053 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Leroy A. 

Richardson, Information Collection 

Review Office, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road NE, MS–D74, Atlanta, Georgia 

30329; phone: 404–639–7570; Email: 

omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Data Collection Through Web Based 

Surveys for Evaluating Act Against 

AIDS Social Marketing Campaign 

Phases Targeting Consumers— 

Extension—National Center for HIV/ 

AIDS, Viral Hepatitis, STD and TB 

Prevention (NCHHSTP, Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

In response to the continued HIV 

epidemic in our country, CDC launched 

Act Against AIDS (AAA), a multifaceted 

communication campaign to reduce HIV 

incidence in the United States in 2009. 

CDC has released the campaign in 

phases, with some of the phases running 

concurrently. Each phase of the 

campaign uses mass media and directto-consumer channels to deliver 

messages. Some campaigns provide 

basic education and increase awareness 

of HIV/AIDS among the general public 

whereas others emphasize HIV 

prevention and testing among specific 

subgroups or communities at greatest 

risk of infection. CDC will also develop 

new messages to address changes in 

prevention science and subpopulations 

affected by HIV. The proposed study 

will assess the effectiveness of these 

social marketing messages aimed at 

increasing HIV/AIDS awareness, 

increasing prevention behaviors, and 

improving HIV testing rates among 

consumers. 

This extension of an ongoing study 

will allow for continued evaluation of 

the effectiveness of AAA social 

marketing campaign through surveys 

with consumers. A total of 10,750 

respondents were approved for the 

previously renewed generic ICR (0920– 

0920) and since the approval date, 4,305 

respondents were surveyed under the 

GenIC, ‘‘Development of Messages for 


daltland on DSKBBV9HB2PROD with NOTICES